[an error occurred while processing this directive]

Journal of Chinese Integrative Medicine ›› 2007, Vol. 5 ›› Issue (5): 559-563.doi: 10.3736/jcim20070517

• Original Experimental Research • Previous Articles     Next Articles

Effects of melittin on expressions of mitochondria membrane protein 7A6, cell apoptosis-related gene products Fas and Fas Ligand in hepatocarcinoma cells

Chen Zhang, Bai Li, Shu-qin Lu, Yong Li, Yong-hua Su, Chang-quan Ling   

  1. Department of T raditional Chinese Medicine ,Changhai Hospital ,Second Military Medical University , Shanghai 200433 ,China
  • Online:2007-09-20 Published:2007-09-15

Objective: To observe the effects of melittin on the expressions of mitochondria membrane protein 7A6, cell apoptosis-related gene products Fas and Fas ligand (FasL) in hepatocarcinoma cells in vitro and to study the mechanisms of melittin in inducing apoptosis of hepatocarcinoma cells.Methods: BEL-7402 cell line was treated with melittin in vitro. The expressions of mitochondria membrane protein 7A6, cell apoptosis-related gene products Fas and FasL were detected by flow cytometry. Fas and FasL mRNAs were analyzed by reverse transcription polymerase chain reaction (RT-PCR) assay.Results: The expression rates of mitochondria membrane protein 7A6 of BEL-7402 hepatocarcinoma cells in 8, 16, 32 μg/ml melittin-treated and control groups were 4.89%, 17.74%, 11.45% and 1.02%, respectively. The expression of Fas protein was up-regulated by melittin, while FasL expression did not change. RT-PCR results showed that Fas mRNA expression was up-regulated by 32 μg/ml melittin and FasL mRNA expression was not observed.Conclusion: The effects of melittin in inducing hepatocarcinoma cell apoptosis may be related with up-regulating the expressions of mitochondria membrane protein 7A6 and Fas protein.

Key words: melittin, liver cancer, mitochondrial proteins, Fas antigens

CLC Number: 

  • R735.7

Figure 1

Effect of melittin on expression of 7A6 protein of BEL-7402 cellsA: Isotype; B: Control group; C: 8 μg/ml melittin-treated group; D: 16 μg/ml melittin-treated group; E: 32 μg/ml melittin-treated group."

Figure 2

Effects of melittin on expressions of Fas protein and FasL of BEL-7402 cellsn=4; *P<0.05, **P<0.01, vs control group."

Table 1

Fas mRNA expression in BEL-7402 cells treated with different concentrations of melittin (ヌ±S)"

Group Fas β-actin Ratio
Control 207.67±11.52 176.33±10.59 1.17±0.13
8 μg/ml melittin-treated 172.00±12.42 158.67±10.53 1.10±0.19
16 μg/ml melittin-treated 176.00±12.42 158.10±10.52 1.19±0.17
32 μg/ml melittin-treated 170.67±6.11 147.00±9.53 1.36±0.13*

Figure 3

Electropherogram of Fas mRNAA: β-actin; B: Fas; M: Marker; C: Control group; 1: 8 μg/ml melittin-treated group; 2: 16 μg/ml melittin-treated group; 3: 32 μg/ml melittin-treated group."

Figure 4

Electropherogram of FasL mRNAA: β-actin; B: FasL; M: Marker; C: Control group; 1: 8 μg/ml melittin-treated group; 2: 16 μg/ml melittin-treated group; 3: 32 μg/ml melittin-treated group."

[1] 张晨, 万旭英, 李柏 , 等. 蜂毒素对肝癌细胞系BEL-7402细胞凋亡的影响[J]. 安徽中医学院学报, 2003,22(4):44-46
Zhang C, Wan XY, Li B , et al. Effect of melittin on apoptosis of hepatocarcinoma cell line BEL-7402[J]. Anhui Zhong Yi Xue Yuan Xue Bao, 2003,22(4):44-46
[2] 李柏, 凌昌全, 张晨 , 等. 蜂毒素基因重组腺病毒诱导肝癌细胞凋亡的作用[J]. 中华肝脏病杂志, 2004,12(8):453-455
Li B, Ling CQ, Zhang C . et al. Induced apoptosis of recombinant adenovirus carrying melittin gene for hepatocellular carcinoma cell[J]. Zhonghua Gan Zang Bing Za Zhi, 2004,12(8):453-455
[3] 陈永强, 朱振安, 郝永强 , 等. 蜂毒素诱导骨肉瘤细胞U2OS凋亡与坏死的实验研究[J]. 中西医结合学报, 2004,2(3):208-209
Chen YQ, Zhu ZA, Hao YQ . et al. Effect of melittin on apoptsis and necrosis of U2OS cells[J]. Zhong Xi Yi Jie He Xue Bao, 2004,2(3):208-209
[4] Itoh N, Yonehara S, Ishii A , et al. The polypeptide encoded by cDNA for human cell surface antigen Fas can mediate apoptosis[J]. Cell, 1991,66(2):233-243
doi: 10.1016/0092-8674(91)90614-5 pmid: 1713127
[5] Houghton JA, Harwood FG , Tillman DM.Thymineless death in colon carcinoma cells is mediated via Fas signaling[J].Proc Natl Acad Sci U S A, 1997, 94(): 8144-8149
[6] 刘岭, 凌昌全, 黄雪强 . 蜂毒素的纯化方法及体外抗肿瘤研究[J]. 中国生化药物杂志, 2003,24(4):163-166
Liu L, Ling CQ, Huang XQ . Study on purification of melittin and its effect on anti-tumor in vitro[J]. Zhongguo Sheng Hua Yao Wu Za Zhi, 2003,24(4):163-166
[7] 张晨, 凌昌全, 李柏 , 等. 蜂毒素对肝癌细胞系SMMC7721增殖的影响[J]. 中草药, 2003,34(1):43-45
Zhang C, Ling CQ, Li B . Effect of melittin on proliferation of hepatocarcinoma cell line SMMC7721[J]. Zhong Cao Yao, 2003,34(1):43-45
[8] 凌昌全, 李柏, 张晨 , 等. 蜂毒素基因重组腺病毒体内外抗肝癌作用实验[J]. 中华肝脏病杂志, 2004,12(12):741-744
Ling CQ, Li B, Zhang C , et al. Anti-hepatocarcinoma effect of recombinant adenovirus carrying melittin gene[J]. Zhonghua Gan Zang Bing Za Zhi, 2004,12(12):741-744
[9] Ling CQ, Li B, Zhang C , et al. Inhibitory effect of recombinant adenovirus carrying melittin gene on hepatocellular carcinoma[J]. Ann Oncol, 2005,16(1):109-115
doi: 10.1093/annonc/mdi019 pmid: 15598947
[10] Zhang C, Ao Z, Seth A , et al. A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells[J]. J Immunol, 1996,157(9):3980-3987
[11] Koester SK, Roth P, Mikulka WR , et al. Monitoring early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal antibody APO2.7[J]. Cytometry, 1997,29(4):306-312
[12] 顾伟, 韩克起, 苏永华 , 等. 蟾毒灵对裸鼠人肝癌移植瘤的抑制作用及对Bcl-2和Bax蛋白表达的影响[J]. 中西医结合学报, 2007,5(2):155-159
Gu W, Han KQ, Su YH , et al. Inhibition action of bufalin on human transplanted hepatocellular tumor and its effects on expressions of Bcl-2 and Bax proteins in nude mice[J]. Zhong Xi Yi Jie He Xue Bao, 2007,5(2):155-159
[13] Métivier D, Dallaporta B, Zamzami N , et al. Cytofluorometric detection of mitochondrial alterations in early CD95/Fas/APO-1-triggered apoptosis of Jurkat T lymphoma cells. Comparison of seven mitochondrion-specific fluorochromes[J]. Immunol Lett, 1998,61(2-3):157-163
[14] Suda T, Okazaki T, Naito Y , et al. Expression of the ligand in cells of T cell lineage[J]. J Immunol, 1995,154(8):3806-3813
doi: 10.3357/ASEM.21011.2010 pmid: 7706720
[1] Huo-jun Zhang, Ji-jin Yang, Wei-xing Wang, Xu Jiang, Yan-jun Mao, Chao-ai Yang, Ji-xiang Guo. Effects of Jinlong Capsule on expressions of interleukin-2 and soluble interleukin-2 receptor in patients with primary liver cancer after transarterial chemoembolization therapy. Journal of Chinese Integrative Medicine, 2008, 6(9): 907-910.
[2] Zhi-qiang Pan, Zhao-qin Fang, Wen-li Lu, Chao Liang, Zhong-hua Wu, Xiao-mei Liu, Li Hou, Hui Zhang, Shao-yuan Zhuo, Ming-juan Liao, Bi-feng Gao. Differentially expressed genes in adrenal gland of H22 liver cancer mice with different syndromes and in different stages. Journal of Chinese Integrative Medicine, 2008, 6(8): 843-851.
[3] Zhi-jun Dai, Xi-jing Wang, Qian Xue, Zong-zheng Ji, Xiao-xu Liu, Hua-feng Kang, Hai-tao Guan, Xiao-bin Ma, Hong-tao Ren. Effects of Scutellaria Barbata drug-containing serum on apoptosis and mitochondrial transmembrane potential of hepatoma H22 cells. Journal of Chinese Integrative Medicine, 2008, 6(8): 821-826.
[4] Zhi-jun Dai, Xi-jing Wang, Zong-zheng Ji, Zong-fang Li, Wei Tang, Hua-feng Kang, Xiao-bin Ma, Lei Liu. Scutellaria barbata extract enhances efficacy and reduces toxicity of chemotherapy in hepatoma H22-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(7): 720-724.
[5] Hong-yun Chen, Zhe Chen. Transcatheter arterial chemoembolization combined with other therapies for the treatment of primary hepatic carcinoma: a review. Journal of Chinese Integrative Medicine, 2008, 6(4): 422-426.
[6] Zhao-cheng Zhu, Qing-bo Lang, Zhe Chen, Dong-tao Li, Chang-quan Ling. Evaluation of Chinese version of the Functional Assessment of Cancer Therapy-Hepatobiliary questionnaire. Journal of Chinese Integrative Medicine, 2008, 6(4): 341-345.
[7] Hai-bo Yu, Cheng-en Pan, Wu-jun Wu, Si-hai Zhao, Hui-feng Zhang. Effects of resveratrol on matrix metalloproteinase-9 expression in hepatoma cells. Journal of Chinese Integrative Medicine, 2008, 6(3): 270-273.
[8] Zhen Sun, Yong-hua Su, Xiao-qiang Yue. Professor Ling Changquan's experience in treating primary liver cancer: an analysis of herbal medication. Journal of Chinese Integrative Medicine, 2008, 6(12): 1221-1225.
[9] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82.
[10] Ju-yong Wang, Zhen-ye Xu. Effects of NK-104 on apoptosis and caspase-3 activity in hepatocellular carcinoma cells. Journal of Chinese Integrative Medicine, 2007, 5(3): 298-301.
[11] Wei Gu, Ke-qi Han, Yong-hua Su, Xue-qiang Huang, Chang-quan Ling. Inhibition action of bufalin on human transplanted hepatocellular tumor and its effects on expressions of Bcl-2 and Bax proteins in nude mice. Journal of Chinese Integrative Medicine, 2007, 5(2): 155-159.
[12] Xiao-yan Mu, Ai-guang Zhao. Progress in research of traditional Chinese medicine in inducing differentiation of human hepatoma cells. Journal of Chinese Integrative Medicine, 2007, 5(1): 92-96.
[13] Ying-lu Feng, Chang-quan Ling, De-zeng Zhu, Chao-qin Yu, Zhe Chen, Bai Li. Ginsenosides combined with dexamethasone in preventing and treating postembolization syndrome following transcatheter arterial chemoembolization: A randomized, controlled and double-blinded prospective trial. Journal of Chinese Integrative Medicine, 2005, 3(2): 99-102.
[14] Chang-quan Ling, Qing Liu, Dong-tao Li, Xiao-qiang Yue, Feng-gang Hou, De-zeng Zhu, Chao-qin Yu, Zhe Chen, Xiao-feng Zhai, Yang Yu. Study of a qualitative diagnostic criterion for basic syndromes of traditional Chinese medicine in patients with primary liver cancer. Journal of Chinese Integrative Medicine, 2005, 3(2): 95-98.
[15] Wei Gu, Jie Shen, Xiao-feng Zhai. Preliminary study on biological behavior and staging of transplanted hepatoma in rats. Journal of Chinese Integrative Medicine, 2005, 3(2): 136-138.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5] . Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[6] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8] Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[9] Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[10] Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228
[an error occurred while processing this directive]